益生菌,肠道微生物群和大脑健康:探索治疗途径
Srirengaraj Vijayaram1,2, Karthikeyan Mahendran3, Hary Razafindralambo4,5
1Xiamen Key Laboratory for Feed Quality Testing and Safety Evaluation, Fisheries College, Jimei University, Xiamen 361021, China.
AIMS microbiology
|October 13, 2025
概括
精神病菌,有益的肠道微生物,通过影响肠-大脑轴,显示出治疗神经系统疾病的潜力. 这项研究探讨了它们的机制和对帕金森病和阿尔茨海默病等疾病的治疗应用.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物组显著影响胃肠道功能和肠-大脑轴.
- 这个轴涉及胃肠道和中枢神经系统之间的双向通信.
- 微生物影响消化,免疫和神经生理学.
研究的目的:
- 为了研究精神生物,具有神经活性性质的益生菌,用于神经系统疾病.
- 检查心理生物药物影响大脑功能的机制.
- 审查目前的应用和精神病菌药物的治疗潜力.
主要方法:
- 文献综述整合了微生物组研究,神经免疫学和临床研究.
- 分析精神生物机制:神经炎症调节,神经递质生产,HPA轴调节和迷走神经信号传递.
- 对帕金森病,阿尔茨海默病,多发性硬化症和自闭症谱系障碍中的精神生物应用的检查.
主要成果:
- 精神生物药物通过神经炎症调节,神经递质合成 (GABA,血清素),HPA轴调节和迷走神经信号传递来影响大脑功能.
- 有证据表明,它对各种神经系统疾病有潜在的治疗应用.
- 已经确定了有前途的微生物菌株和针对性干预的机制途径.
结论:
- 精神生物药物为神经疾病提供了新的治疗途径.
- 有针对性的微生物干预可以补充传统的神经疗法.
- 进一步的研究是必要的,以确认菌株特异性疗效,长期影响和安全性.
相关概念视频
Microorganisms in Medicine and Therapeutics
960
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
960
Physiology of Enteric Nervous System and Gut Health
870
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
870
Brain Imaging
663
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
663
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
637
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
637
Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K


